Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration

Table 3 Example of a summary of findings table that includes a separate row to show the absolute events for disadvantaged groups

Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Patient or population: Children aged between 6 months and five years
Intervention: Vitamin A supplementation
Comparison: Placebo or usual care
Outcomes	Illustrative comparative risks^a (95 % CI)		Relative effect (95 % CI)	No. of Participants (studies)	Quality of the evidence (GRADE)	Comments
Diarrhoea-related mortality	Low risk population		RR 0.72; 95 % CI 0.57 to 0.91	90,951 (7 studies)	+++O moderate²	Total number of participants reflects number randomised to studies. The analysis combined cumulative risk and risk per/1000 years follow-up.
Diarrhoea-related mortality	3 per 1000¹	2 per 1000 (2 to 3)
Follow-up: 48–104 weeks	Medium risk population
	4 per 1000¹	3 per 1000 (2 to 4)
	High risk population
	9 per 1000¹	6 per 1000 (5 to 8)

ISSN: 1475-9276